Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

24 Sep 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/potential-11b-deal-glenmark-grabs-certain-rights-hengrui-adc-rival-enhertu

29 Jul 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/jiangsu-hengrui-grants-gsk-global-rights-drug-portfolio-500-million-deal-2025-07-28/

22 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ideaya-biosciences-and-hengrui-pharmaceuticals-announce-oral-presentation-at-iaslc-2025-world-conference-on-lung-cancer-for-ide849-shr-4849-a-potential-first-in-class-dll3-top1-adc-302510323.html

05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hengrui-pharma-showcases-global-impact-at-the-2025-asco-72-study-results-highlight-chinese-cancer-innovation-302474128.html

01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hengruis-camrelizumab-combo-therapy-doubles-the-five--year-survival-of-patients-with-advanced-squamous-lung-cancer---a-potential--paradigm-shift-in-clinical-outcome-for-this-difficult-to-treat-population-302416809.html

29 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ideaya-biosciences-enters-exclusive-license-with-hengrui-pharma-for-shr-4849-a-novel-phase-1-dll3-topo-i-payload-adc-targeting-sclc-and-net-solid-tumors-302339847.html
Inspections and registrations
ABOUT THIS PAGE